NCT00238914View on ClinicalTrials.gov

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Heroin Dependence
Interventions
DRUG

Naltrexone

50mg of oral naltrexone daily

BEHAVIORAL

Behavioral Naltrexone Therapy (BNT)

a hybrid of Relapse Prevention, the Community Reinforcement Approach, and Network Therapy

BEHAVIORAL

Compliance Enhancement (CE)

a controlled therapy intended to simulate outpatient psychiatric care.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00238914 - Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 | Biotech Hunter | Biotech Hunter